General Information
Version
6.4
Revision date
2025-10-13
Product name
DNA Ligation Kit
REACH No
This
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
none
Hazard Codes
Hazard statements (CLP)
H319, H334
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Eye irritation, (Category 2) H319: Causes serious eye irritation. Respiratory sensitisation, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled.
Hazard pictograms
none
Signal word
none Danger Danger
Hazard statements
none H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
none P261 Avoid breathing mist or vapours. P264 Wash skin thoroughly after handling. P280 Wear eye protection/ face protection. P284 Wear respiratory protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention. P261 Avoid breathing mist or vapours. P284 Wear respiratory protection.
Supplemental label elements
none none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.